Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment

By Rajeev S.   Kania S.A.   Nair R.V.   McPherson J.T.   Moore R.N.   Bemis D.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4842-4850

Elsevier

Access to resources Recommend Favorite

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile

By Boslego J.   Garcia J.   Cruz C.   Zollinger W.   Brandt B.   Ruiz S.   Martinez M.   Arthur J.   Underwood P.   Silva W.   Moran E.   Hankins W.   Gilly J.   Mays J.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 821-829

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers

By von Specht B.-U.   Lucking H.C.   Blum B.   Schmitt A.   Hungerer K.D.   Domdey H.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1111-1117

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins

By Cartwright K.   Morris R.   Rumke H.   Fox A.   Ray Borrow   Begg N.   Richmond P.   Poolman J.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2612-2619

Elsevier

Access to resources Recommend Favorite

Efficacy of recombinant sialoglycoprotease in protection of cattle against pneumonic challenge with Mannheimia (Pasteurella) haemolytica A1

By Shewen P.E.   Lee C.W.   Perets A.   Hodgins D.C.   Baldwin K.   Lo R.Y.C.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1901-1906

Elsevier

Access to resources Recommend Favorite